{"transactions":[{"id":715213,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":1,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":2,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32123,"kind":"organization","name":"ARCH Venture Fund X Overage, L.P.","position":3,"cik":"0001757017","reported_name":"ARCH Venture Fund X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":4,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":5,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32126,"kind":"organization","name":"ARCH Venture Partners X Overage, L.P.","position":6,"cik":"0001768905","reported_name":"ARCH Venture Partners X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":7,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":8,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-06T21:43:19.000Z","date":"2026-07-01","kind":"exercise","planned":false,"acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option vested in substantially equal monthly installments over the 11 months following June 23, 2025. The final unvested portion vested on June 15, 2026, the date of the Issuer's 2026 annual meeting of stockholders."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents a cashless stock option exercise by Kristina Burow. The net proceeds of such exercise were remitted to ARCH Venture Fund IX, L.P. (ARCH IX), ARCH Venture Fund IX Overage, L.P. (ARCH IX Overage), and ARCH Venture Fund X, L.P. (AVF X Overage LP). The stock option was granted to Kristina Burow in connection with her service on the board of directors of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":1.03,"expiration_date":"2035-06-22","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001012975-26-000621","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1666307/000101297526000621/form4.xml","form_type":"4"}},{"id":715212,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":1,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":2,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32123,"kind":"organization","name":"ARCH Venture Fund X Overage, L.P.","position":3,"cik":"0001757017","reported_name":"ARCH Venture Fund X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":4,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":5,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32126,"kind":"organization","name":"ARCH Venture Partners X Overage, L.P.","position":6,"cik":"0001768905","reported_name":"ARCH Venture Partners X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":7,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":8,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-07-06T21:43:19.000Z","date":"2026-07-01","kind":"sale","planned":false,"acquired":false,"shares":16000,"price":2.49,"value":39840.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents a cashless stock option exercise by Kristina Burow. The net proceeds of such exercise were remitted to ARCH Venture Fund IX, L.P. (ARCH IX), ARCH Venture Fund IX Overage, L.P. (ARCH IX Overage), and ARCH Venture Fund X, L.P. (AVF X Overage LP). The stock option was granted to Kristina Burow in connection with her service on the board of directors of the Issuer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001012975-26-000621","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1666307/000101297526000621/form4.xml","form_type":"4"}},{"id":715211,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":1,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":2,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32123,"kind":"organization","name":"ARCH Venture Fund X Overage, L.P.","position":3,"cik":"0001757017","reported_name":"ARCH Venture Fund X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":4,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":5,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32126,"kind":"organization","name":"ARCH Venture Partners X Overage, L.P.","position":6,"cik":"0001768905","reported_name":"ARCH Venture Partners X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":7,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":8,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-07-06T21:43:19.000Z","date":"2026-07-01","kind":"exercise","planned":false,"acquired":true,"shares":16000,"price":1.03,"value":16480.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents a cashless stock option exercise by Kristina Burow. The net proceeds of such exercise were remitted to ARCH Venture Fund IX, L.P. (ARCH IX), ARCH Venture Fund IX Overage, L.P. (ARCH IX Overage), and ARCH Venture Fund X, L.P. (AVF X Overage LP). The stock option was granted to Kristina Burow in connection with her service on the board of directors of the Issuer."}],"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001012975-26-000621","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666307/000101297526000621/form4.xml","form_type":"4"}},{"id":853633,"issuer":{"id":5757,"kind":"organization","name":"Lyell Immunopharma, Inc.","symbol":"LYEL"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-09T20:36:20.000Z","date":"2026-03-06","kind":"purchase","planned":false,"acquired":true,"shares":488090,"price":25.61,"value":12499984.9,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are directly held by ARCH Venture Fund XIII, L.P. (\"ARCH XIII\"). ARCH Venture Partners XIII, L.P. (\"AVP XIII LP\") is the general partner of ARCH XIII. ARCH Venture Partners XIII, LLC (\"AVP XIII LLC\") is the general partner of AVP XIII LP.  Keith Crandell, Robert Nelsen, Kristina Burow, Paul Berns and Steven Gillis are members of the investment committee of AVP XIII LLC (the \"AVP XIII LLC Committee Members\"). Each of AVP XIII LP and AVP XIII LLC may be deemed to beneficially own the shares held by ARCH XIII, and each of the AVP XIII LLC Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH XIII. Each of AVP XIII LP, AVP XIII LLC and the AVP XIII LLC Committee Members disclaims beneficial ownership except to the extent of their pecuniary interest therein, if any."}],"balance_after":1426528,"source":{"system":"sec-edgar","filing":"0001012975-26-000235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1806952/000101297526000235/form4.xml","form_type":"4"}},{"id":1547768,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":1,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":2,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32123,"kind":"organization","name":"ARCH Venture Fund X Overage, L.P.","position":3,"cik":"0001757017","reported_name":"ARCH Venture Fund X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":4,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":5,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32126,"kind":"organization","name":"ARCH Venture Partners X Overage, L.P.","position":6,"cik":"0001768905","reported_name":"ARCH Venture Partners X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":7,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":8,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2024-04-04T20:30:30.000Z","date":"2024-04-02","kind":"exercise","planned":false,"acquired":false,"shares":366301,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held directly by ARCH Venture Fund X Overage, L.P. (ARCH X Overage).  ARCH Venture Partners X Overage, L.P. (AVP X Overage LP) is the sole general partner of ARCH X Overage."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of AVP X Overage LP. Keith Crandell, Robert Nelsen and Steven Gillis are members of the investment committee of AVP X LLC (the AVP X Committee Members). AVP X Overage LP may be deemed to beneficially own the shares held by ARCH X Overage, AVP X LLC may be deemed to beneficially own the shares held by ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X Overage. AVP X Overage LP, AVP X LLC, and the AVP X Committee Members each disclaim beneficial ownership except to the extent of any pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":366301},"source":{"system":"sec-edgar","filing":"0000950170-24-041841","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1666307/000095017024041841/ownership.xml","form_type":"4"}},{"id":1547767,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":1,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":2,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32123,"kind":"organization","name":"ARCH Venture Fund X Overage, L.P.","position":3,"cik":"0001757017","reported_name":"ARCH Venture Fund X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":4,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":5,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32126,"kind":"organization","name":"ARCH Venture Partners X Overage, L.P.","position":6,"cik":"0001768905","reported_name":"ARCH Venture Partners X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":7,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":8,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2024-04-04T20:30:30.000Z","date":"2024-04-02","kind":"exercise","planned":false,"acquired":false,"shares":201465,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held directly by ARCH Venture Fund IX Overage, L.P. (ARCH IX Overage).  ARCH Venture Partners IX Overage, L.P. (AVP IX Overage LP) is the sole general partner of ARCH IX Overage."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"ARCH Venture Partners IX, LLC (AVP IX LLC) is the sole general partner of each of AVP IX LP and AVP IX Overage LP. Keith Crandell, Robert Nelsen and Clinton Bybee are managing directors of AVP IX LLC (the AVP IX MDs). AVP IX LP and AVP IX Overage LP may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, respectively, AVP IX LLC may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, and each of the AVP IX MDs may be deemed to share the power to direct the disposition and vote of the shares held by ARCH IX and ARCH IX Overage. AVP IX LP, AVP IX Overage LP, AVP IX LLC, and the AVP IX MDs each disclaim beneficial ownership except to to the extent of any pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":201465},"source":{"system":"sec-edgar","filing":"0000950170-24-041841","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1666307/000095017024041841/ownership.xml","form_type":"4"}},{"id":1547766,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":1,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":2,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32123,"kind":"organization","name":"ARCH Venture Fund X Overage, L.P.","position":3,"cik":"0001757017","reported_name":"ARCH Venture Fund X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":4,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":5,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32126,"kind":"organization","name":"ARCH Venture Partners X Overage, L.P.","position":6,"cik":"0001768905","reported_name":"ARCH Venture Partners X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":7,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":8,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2024-04-04T20:30:30.000Z","date":"2024-04-02","kind":"exercise","planned":false,"acquired":false,"shares":164835,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held directly by ARCH Venture Fund IX, L.P. (ARCH IX).  ARCH Venture Partners IX, L.P. (AVP IX LP) is the sole general partner of ARCH IX."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"ARCH Venture Partners IX, LLC (AVP IX LLC) is the sole general partner of each of AVP IX LP and AVP IX Overage LP. Keith Crandell, Robert Nelsen and Clinton Bybee are managing directors of AVP IX LLC (the AVP IX MDs). AVP IX LP and AVP IX Overage LP may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, respectively, AVP IX LLC may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, and each of the AVP IX MDs may be deemed to share the power to direct the disposition and vote of the shares held by ARCH IX and ARCH IX Overage. AVP IX LP, AVP IX Overage LP, AVP IX LLC, and the AVP IX MDs each disclaim beneficial ownership except to to the extent of any pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":164835},"source":{"system":"sec-edgar","filing":"0000950170-24-041841","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1666307/000095017024041841/ownership.xml","form_type":"4"}},{"id":1547765,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":1,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":2,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32123,"kind":"organization","name":"ARCH Venture Fund X Overage, L.P.","position":3,"cik":"0001757017","reported_name":"ARCH Venture Fund X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":4,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":5,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32126,"kind":"organization","name":"ARCH Venture Partners X Overage, L.P.","position":6,"cik":"0001768905","reported_name":"ARCH Venture Partners X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":7,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":8,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2024-04-04T20:30:30.000Z","date":"2024-04-02","kind":"exercise","planned":false,"acquired":false,"shares":227920,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held directly by ARCH Venture Fund X Overage, L.P. (ARCH X Overage).  ARCH Venture Partners X Overage, L.P. (AVP X Overage LP) is the sole general partner of ARCH X Overage."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of AVP X Overage LP. Keith Crandell, Robert Nelsen and Steven Gillis are members of the investment committee of AVP X LLC (the AVP X Committee Members). AVP X Overage LP may be deemed to beneficially own the shares held by ARCH X Overage, AVP X LLC may be deemed to beneficially own the shares held by ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X Overage. AVP X Overage LP, AVP X LLC, and the AVP X Committee Members each disclaim beneficial ownership except to the extent of any pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":227920},"source":{"system":"sec-edgar","filing":"0000950170-24-041841","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1666307/000095017024041841/ownership.xml","form_type":"4"}},{"id":1547764,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":1,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":2,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32123,"kind":"organization","name":"ARCH Venture Fund X Overage, L.P.","position":3,"cik":"0001757017","reported_name":"ARCH Venture Fund X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":4,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":5,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32126,"kind":"organization","name":"ARCH Venture Partners X Overage, L.P.","position":6,"cik":"0001768905","reported_name":"ARCH Venture Partners X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":7,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":8,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2024-04-04T20:30:30.000Z","date":"2024-04-02","kind":"exercise","planned":false,"acquired":false,"shares":454212,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held directly by ARCH Venture Fund X Overage, L.P. (ARCH X Overage).  ARCH Venture Partners X Overage, L.P. (AVP X Overage LP) is the sole general partner of ARCH X Overage."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of AVP X Overage LP. Keith Crandell, Robert Nelsen and Steven Gillis are members of the investment committee of AVP X LLC (the AVP X Committee Members). AVP X Overage LP may be deemed to beneficially own the shares held by ARCH X Overage, AVP X LLC may be deemed to beneficially own the shares held by ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X Overage. AVP X Overage LP, AVP X LLC, and the AVP X Committee Members each disclaim beneficial ownership except to the extent of any pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":454212},"source":{"system":"sec-edgar","filing":"0000950170-24-041841","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1666307/000095017024041841/ownership.xml","form_type":"4"}},{"id":1547763,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":1,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":2,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32123,"kind":"organization","name":"ARCH Venture Fund X Overage, L.P.","position":3,"cik":"0001757017","reported_name":"ARCH Venture Fund X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":4,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":5,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32126,"kind":"organization","name":"ARCH Venture Partners X Overage, L.P.","position":6,"cik":"0001768905","reported_name":"ARCH Venture Partners X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":7,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":8,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2024-04-04T20:30:30.000Z","date":"2024-04-02","kind":"exercise","planned":false,"acquired":false,"shares":586080,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held directly by ARCH Venture Fund IX Overage, L.P. (ARCH IX Overage).  ARCH Venture Partners IX Overage, L.P. (AVP IX Overage LP) is the sole general partner of ARCH IX Overage."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"ARCH Venture Partners IX, LLC (AVP IX LLC) is the sole general partner of each of AVP IX LP and AVP IX Overage LP. Keith Crandell, Robert Nelsen and Clinton Bybee are managing directors of AVP IX LLC (the AVP IX MDs). AVP IX LP and AVP IX Overage LP may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, respectively, AVP IX LLC may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, and each of the AVP IX MDs may be deemed to share the power to direct the disposition and vote of the shares held by ARCH IX and ARCH IX Overage. AVP IX LP, AVP IX Overage LP, AVP IX LLC, and the AVP IX MDs each disclaim beneficial ownership except to to the extent of any pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":586080},"source":{"system":"sec-edgar","filing":"0000950170-24-041841","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1666307/000095017024041841/ownership.xml","form_type":"4"}},{"id":1547762,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":1,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":2,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32123,"kind":"organization","name":"ARCH Venture Fund X Overage, L.P.","position":3,"cik":"0001757017","reported_name":"ARCH Venture Fund X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":4,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":5,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32126,"kind":"organization","name":"ARCH Venture Partners X Overage, L.P.","position":6,"cik":"0001768905","reported_name":"ARCH Venture Partners X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":7,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":8,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2024-04-04T20:30:30.000Z","date":"2024-04-02","kind":"exercise","planned":false,"acquired":false,"shares":424908,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held directly by ARCH Venture Fund IX, L.P. (ARCH IX).  ARCH Venture Partners IX, L.P. (AVP IX LP) is the sole general partner of ARCH IX."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"ARCH Venture Partners IX, LLC (AVP IX LLC) is the sole general partner of each of AVP IX LP and AVP IX Overage LP. Keith Crandell, Robert Nelsen and Clinton Bybee are managing directors of AVP IX LLC (the AVP IX MDs). AVP IX LP and AVP IX Overage LP may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, respectively, AVP IX LLC may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, and each of the AVP IX MDs may be deemed to share the power to direct the disposition and vote of the shares held by ARCH IX and ARCH IX Overage. AVP IX LP, AVP IX Overage LP, AVP IX LLC, and the AVP IX MDs each disclaim beneficial ownership except to to the extent of any pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":424908},"source":{"system":"sec-edgar","filing":"0000950170-24-041841","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1666307/000095017024041841/ownership.xml","form_type":"4"}},{"id":1547761,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":1,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":2,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32123,"kind":"organization","name":"ARCH Venture Fund X Overage, L.P.","position":3,"cik":"0001757017","reported_name":"ARCH Venture Fund X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":4,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":5,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32126,"kind":"organization","name":"ARCH Venture Partners X Overage, L.P.","position":6,"cik":"0001768905","reported_name":"ARCH Venture Partners X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":7,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":8,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-04T20:30:30.000Z","date":"2024-04-02","kind":"purchase","planned":false,"acquired":true,"shares":133333,"price":16,"value":2133328.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held directly by ARCH Venture Fund X Overage, L.P. (ARCH X Overage).  ARCH Venture Partners X Overage, L.P. (AVP X Overage LP) is the sole general partner of ARCH X Overage."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of AVP X Overage LP. Keith Crandell, Robert Nelsen and Steven Gillis are members of the investment committee of AVP X LLC (the AVP X Committee Members). AVP X Overage LP may be deemed to beneficially own the shares held by ARCH X Overage, AVP X LLC may be deemed to beneficially own the shares held by ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X Overage. AVP X Overage LP, AVP X LLC, and the AVP X Committee Members each disclaim beneficial ownership except to the extent of any pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Represents shares purchased by ARCH X Overage in the Issuer's initial public offering."}],"balance_after":1181766,"source":{"system":"sec-edgar","filing":"0000950170-24-041841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1666307/000095017024041841/ownership.xml","form_type":"4"}},{"id":1547760,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":1,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":2,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32123,"kind":"organization","name":"ARCH Venture Fund X Overage, L.P.","position":3,"cik":"0001757017","reported_name":"ARCH Venture Fund X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":4,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":5,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32126,"kind":"organization","name":"ARCH Venture Partners X Overage, L.P.","position":6,"cik":"0001768905","reported_name":"ARCH Venture Partners X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":7,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":8,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-04T20:30:30.000Z","date":"2024-04-02","kind":"purchase","planned":false,"acquired":true,"shares":66667,"price":16,"value":1066672.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held directly by ARCH Venture Fund IX, L.P. (ARCH IX).  ARCH Venture Partners IX, L.P. (AVP IX LP) is the sole general partner of ARCH IX."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"ARCH Venture Partners IX, LLC (AVP IX LLC) is the sole general partner of each of AVP IX LP and AVP IX Overage LP. Keith Crandell, Robert Nelsen and Clinton Bybee are managing directors of AVP IX LLC (the AVP IX MDs). AVP IX LP and AVP IX Overage LP may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, respectively, AVP IX LLC may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, and each of the AVP IX MDs may be deemed to share the power to direct the disposition and vote of the shares held by ARCH IX and ARCH IX Overage. AVP IX LP, AVP IX Overage LP, AVP IX LLC, and the AVP IX MDs each disclaim beneficial ownership except to to the extent of any pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Represents shares purchased by ARCH IX in the Issuer's initial public offering."}],"balance_after":683759,"source":{"system":"sec-edgar","filing":"0000950170-24-041841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1666307/000095017024041841/ownership.xml","form_type":"4"}},{"id":1547759,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":1,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":2,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32123,"kind":"organization","name":"ARCH Venture Fund X Overage, L.P.","position":3,"cik":"0001757017","reported_name":"ARCH Venture Fund X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":4,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":5,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32126,"kind":"organization","name":"ARCH Venture Partners X Overage, L.P.","position":6,"cik":"0001768905","reported_name":"ARCH Venture Partners X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":7,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":8,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-04T20:30:30.000Z","date":"2024-04-02","kind":"exercise","planned":false,"acquired":true,"shares":1048433,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held directly by ARCH Venture Fund X Overage, L.P. (ARCH X Overage).  ARCH Venture Partners X Overage, L.P. (AVP X Overage LP) is the sole general partner of ARCH X Overage."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of AVP X Overage LP. Keith Crandell, Robert Nelsen and Steven Gillis are members of the investment committee of AVP X LLC (the AVP X Committee Members). AVP X Overage LP may be deemed to beneficially own the shares held by ARCH X Overage, AVP X LLC may be deemed to beneficially own the shares held by ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X Overage. AVP X Overage LP, AVP X LLC, and the AVP X Committee Members each disclaim beneficial ownership except to the extent of any pecuniary interest therein, if any."}],"balance_after":1048433,"source":{"system":"sec-edgar","filing":"0000950170-24-041841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1666307/000095017024041841/ownership.xml","form_type":"4"}},{"id":1547758,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":1,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":2,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32123,"kind":"organization","name":"ARCH Venture Fund X Overage, L.P.","position":3,"cik":"0001757017","reported_name":"ARCH Venture Fund X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":4,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":5,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32126,"kind":"organization","name":"ARCH Venture Partners X Overage, L.P.","position":6,"cik":"0001768905","reported_name":"ARCH Venture Partners X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":7,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":8,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-04T20:30:30.000Z","date":"2024-04-02","kind":"exercise","planned":false,"acquired":true,"shares":787545,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held directly by ARCH Venture Fund IX Overage, L.P. (ARCH IX Overage).  ARCH Venture Partners IX Overage, L.P. (AVP IX Overage LP) is the sole general partner of ARCH IX Overage."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"ARCH Venture Partners IX, LLC (AVP IX LLC) is the sole general partner of each of AVP IX LP and AVP IX Overage LP. Keith Crandell, Robert Nelsen and Clinton Bybee are managing directors of AVP IX LLC (the AVP IX MDs). AVP IX LP and AVP IX Overage LP may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, respectively, AVP IX LLC may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, and each of the AVP IX MDs may be deemed to share the power to direct the disposition and vote of the shares held by ARCH IX and ARCH IX Overage. AVP IX LP, AVP IX Overage LP, AVP IX LLC, and the AVP IX MDs each disclaim beneficial ownership except to to the extent of any pecuniary interest therein, if any."}],"balance_after":828570,"source":{"system":"sec-edgar","filing":"0000950170-24-041841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1666307/000095017024041841/ownership.xml","form_type":"4"}},{"id":1547757,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":1,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":2,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32123,"kind":"organization","name":"ARCH Venture Fund X Overage, L.P.","position":3,"cik":"0001757017","reported_name":"ARCH Venture Fund X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":4,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":5,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32126,"kind":"organization","name":"ARCH Venture Partners X Overage, L.P.","position":6,"cik":"0001768905","reported_name":"ARCH Venture Partners X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":7,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":8,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-04T20:30:30.000Z","date":"2024-04-02","kind":"exercise","planned":false,"acquired":true,"shares":589743,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held directly by ARCH Venture Fund IX, L.P. (ARCH IX).  ARCH Venture Partners IX, L.P. (AVP IX LP) is the sole general partner of ARCH IX."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"ARCH Venture Partners IX, LLC (AVP IX LLC) is the sole general partner of each of AVP IX LP and AVP IX Overage LP. Keith Crandell, Robert Nelsen and Clinton Bybee are managing directors of AVP IX LLC (the AVP IX MDs). AVP IX LP and AVP IX Overage LP may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, respectively, AVP IX LLC may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, and each of the AVP IX MDs may be deemed to share the power to direct the disposition and vote of the shares held by ARCH IX and ARCH IX Overage. AVP IX LP, AVP IX Overage LP, AVP IX LLC, and the AVP IX MDs each disclaim beneficial ownership except to to the extent of any pecuniary interest therein, if any."}],"balance_after":617092,"source":{"system":"sec-edgar","filing":"0000950170-24-041841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666307/000095017024041841/ownership.xml","form_type":"4"}},{"id":1649392,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":73809,"kind":"organization","name":"ARCH Venture Fund X, L.P.","position":1,"cik":"0001757011","reported_name":"ARCH Venture Fund X, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32123,"kind":"organization","name":"ARCH Venture Fund X Overage, L.P.","position":2,"cik":"0001757017","reported_name":"ARCH Venture Fund X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":3,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":4,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":5,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":6,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73810,"kind":"organization","name":"ARCH Venture Partners X, L.P.","position":7,"cik":"0001782583","reported_name":"ARCH Venture Partners X, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32126,"kind":"organization","name":"ARCH Venture Partners X Overage, L.P.","position":8,"cik":"0001768905","reported_name":"ARCH Venture Partners X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":9,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":10,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-12T17:43:09.000Z","date":"2024-02-08","kind":"purchase","planned":false,"acquired":true,"shares":727272,"price":5.5,"value":3999996.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held directly by ARCH Venture Fund X Overage, L.P. (ARCH X Overage).  ARCH Venture Partners X Overage, L.P. (AVP X Overage LP) is the sole general partner of ARCH X Overage."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of each of AVP X LP and AVP X Overage LP. Keith Crandell, Kristina Burow and Steven Gillis are members of the investment committee of AVP X LLC (the AVP X Committee Members). AVP X LP and AVP X Overage LP may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, respectively, AVP X LLC may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X and ARCH X Overage. AVP X LP, AVP X Overage LP, AVP X LLC, and the AVP X Committee Members each disclaim beneficial ownership except to the extent of any pecuniary interest therein."}],"balance_after":12446022,"source":{"system":"sec-edgar","filing":"0001062993-24-002840","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1757011/000106299324002840/form4.xml","form_type":"4"}},{"id":1649391,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":73809,"kind":"organization","name":"ARCH Venture Fund X, L.P.","position":1,"cik":"0001757011","reported_name":"ARCH Venture Fund X, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32123,"kind":"organization","name":"ARCH Venture Fund X Overage, L.P.","position":2,"cik":"0001757017","reported_name":"ARCH Venture Fund X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":3,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":4,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":5,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":6,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73810,"kind":"organization","name":"ARCH Venture Partners X, L.P.","position":7,"cik":"0001782583","reported_name":"ARCH Venture Partners X, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32126,"kind":"organization","name":"ARCH Venture Partners X Overage, L.P.","position":8,"cik":"0001768905","reported_name":"ARCH Venture Partners X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":9,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":10,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-12T17:43:09.000Z","date":"2024-02-08","kind":"purchase","planned":false,"acquired":true,"shares":727272,"price":5.5,"value":3999996.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares held directly by ARCH Venture Fund X, L.P. (ARCH X).  ARCH Venture Partners X, L.P. (AVP X LP) is the sole general partner of ARCH X."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of each of AVP X LP and AVP X Overage LP. Keith Crandell, Kristina Burow and Steven Gillis are members of the investment committee of AVP X LLC (the AVP X Committee Members). AVP X LP and AVP X Overage LP may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, respectively, AVP X LLC may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X and ARCH X Overage. AVP X LP, AVP X Overage LP, AVP X LLC, and the AVP X Committee Members each disclaim beneficial ownership except to the extent of any pecuniary interest therein."}],"balance_after":12446022,"source":{"system":"sec-edgar","filing":"0001062993-24-002840","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1757011/000106299324002840/form4.xml","form_type":"4"}},{"id":1649390,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":73809,"kind":"organization","name":"ARCH Venture Fund X, L.P.","position":1,"cik":"0001757011","reported_name":"ARCH Venture Fund X, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32123,"kind":"organization","name":"ARCH Venture Fund X Overage, L.P.","position":2,"cik":"0001757017","reported_name":"ARCH Venture Fund X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":3,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":4,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":5,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":6,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73810,"kind":"organization","name":"ARCH Venture Partners X, L.P.","position":7,"cik":"0001782583","reported_name":"ARCH Venture Partners X, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32126,"kind":"organization","name":"ARCH Venture Partners X Overage, L.P.","position":8,"cik":"0001768905","reported_name":"ARCH Venture Partners X Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":9,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":10,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-12T17:43:09.000Z","date":"2024-02-08","kind":"purchase","planned":false,"acquired":true,"shares":363637,"price":5.5,"value":2000003.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents shares held directly by ARCH Venture Fund IX, L.P. (ARCH IX).  ARCH Venture Partners IX, L.P. (AVP IX LP) is the sole general partner of ARCH IX."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"ARCH Venture Partners IX, LLC (AVP IX LLC) is the sole general partner of each of AVP IX LP and AVP IX Overage LP. Keith Crandell and Clinton Bybee are managing directors of AVP IX LLC (the AVP IX MDs). AVP IX LP and AVP IX Overage LP may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, respectively, AVP IX LLC may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, and each of the AVP IX MDs may be deemed to share the power to direct the disposition and vote of the shares held by ARCH IX and ARCH IX Overage. AVP IX LP, AVP IX Overage LP, AVP IX LLC, and the AVP IX MDs each disclaim beneficial ownership except to to the extent of any pecuniary interest therein."}],"balance_after":10667387,"source":{"system":"sec-edgar","filing":"0001062993-24-002840","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1757011/000106299324002840/form4.xml","form_type":"4"}},{"id":2164170,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T00:29:00.000Z","date":"2022-09-06","kind":"other","acquired":true,"shares":3248,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."}],"balance_after":61160,"source":{"system":"sec-edgar","filing":"0001062993-22-019342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322019342/form4.xml","form_type":"4"}},{"id":2164169,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T00:29:00.000Z","date":"2022-09-06","kind":"other","acquired":true,"shares":1624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":30570,"source":{"system":"sec-edgar","filing":"0001062993-22-019342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322019342/form4.xml","form_type":"4"}},{"id":2164168,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T00:29:00.000Z","date":"2022-09-06","kind":"other","acquired":true,"shares":14383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":272964,"source":{"system":"sec-edgar","filing":"0001062993-22-019342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322019342/form4.xml","form_type":"4"}},{"id":2164167,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T00:29:00.000Z","date":"2022-09-06","kind":"other","acquired":false,"shares":310441,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":7290655,"source":{"system":"sec-edgar","filing":"0001062993-22-019342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322019342/form4.xml","form_type":"4"}},{"id":2164166,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T00:29:00.000Z","date":"2022-09-06","kind":"other","acquired":false,"shares":239559,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":5626008,"source":{"system":"sec-edgar","filing":"0001062993-22-019342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322019342/form4.xml","form_type":"4"}},{"id":2164165,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T00:29:00.000Z","date":"2022-09-02","kind":"other","acquired":true,"shares":2662,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."}],"balance_after":57912,"source":{"system":"sec-edgar","filing":"0001062993-22-019342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322019342/form4.xml","form_type":"4"}},{"id":2164164,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T00:29:00.000Z","date":"2022-09-02","kind":"other","acquired":true,"shares":1338,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":28946,"source":{"system":"sec-edgar","filing":"0001062993-22-019342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322019342/form4.xml","form_type":"4"}},{"id":2164163,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T00:29:00.000Z","date":"2022-09-02","kind":"other","acquired":true,"shares":11763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":258581,"source":{"system":"sec-edgar","filing":"0001062993-22-019342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322019342/form4.xml","form_type":"4"}},{"id":2164162,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T00:29:00.000Z","date":"2022-09-02","kind":"other","acquired":false,"shares":253997,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":7601096,"source":{"system":"sec-edgar","filing":"0001062993-22-019342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322019342/form4.xml","form_type":"4"}},{"id":2164161,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T00:29:00.000Z","date":"2022-09-02","kind":"other","acquired":false,"shares":196003,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":5865567,"source":{"system":"sec-edgar","filing":"0001062993-22-019342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322019342/form4.xml","form_type":"4"}},{"id":2169009,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-01T21:20:33.000Z","date":"2022-08-31","kind":"other","acquired":true,"shares":2952,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."}],"balance_after":55250,"source":{"system":"sec-edgar","filing":"0001062993-22-018984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018984/form4.xml","form_type":"4"}},{"id":2169008,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-01T21:20:33.000Z","date":"2022-08-31","kind":"other","acquired":true,"shares":1475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":27608,"source":{"system":"sec-edgar","filing":"0001062993-22-018984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018984/form4.xml","form_type":"4"}},{"id":2169007,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-01T21:20:33.000Z","date":"2022-08-31","kind":"other","acquired":true,"shares":13076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":246818,"source":{"system":"sec-edgar","filing":"0001062993-22-018984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018984/form4.xml","form_type":"4"}},{"id":2169006,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-01T21:20:33.000Z","date":"2022-08-31","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":7855093,"source":{"system":"sec-edgar","filing":"0001062993-22-018984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018984/form4.xml","form_type":"4"}},{"id":2169005,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-01T21:20:33.000Z","date":"2022-08-31","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":6061570,"source":{"system":"sec-edgar","filing":"0001062993-22-018984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018984/form4.xml","form_type":"4"}},{"id":2169004,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-01T21:20:33.000Z","date":"2022-08-30","kind":"other","acquired":true,"shares":2952,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."}],"balance_after":52298,"source":{"system":"sec-edgar","filing":"0001062993-22-018984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018984/form4.xml","form_type":"4"}},{"id":2169003,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-01T21:20:33.000Z","date":"2022-08-30","kind":"other","acquired":true,"shares":1475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":26133,"source":{"system":"sec-edgar","filing":"0001062993-22-018984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018984/form4.xml","form_type":"4"}},{"id":2169002,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-01T21:20:33.000Z","date":"2022-08-30","kind":"other","acquired":true,"shares":13076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":233742,"source":{"system":"sec-edgar","filing":"0001062993-22-018984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018984/form4.xml","form_type":"4"}},{"id":2169001,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-01T21:20:33.000Z","date":"2022-08-30","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":8137312,"source":{"system":"sec-edgar","filing":"0001062993-22-018984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018984/form4.xml","form_type":"4"}},{"id":2169000,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-01T21:20:33.000Z","date":"2022-08-30","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":6279351,"source":{"system":"sec-edgar","filing":"0001062993-22-018984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018984/form4.xml","form_type":"4"}},{"id":2172908,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T21:12:30.000Z","date":"2022-08-25","kind":"other","acquired":true,"shares":2952,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."}],"balance_after":49346,"source":{"system":"sec-edgar","filing":"0001062993-22-018811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018811/form4.xml","form_type":"4"}},{"id":2172907,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T21:12:30.000Z","date":"2022-08-25","kind":"other","acquired":true,"shares":1475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":24658,"source":{"system":"sec-edgar","filing":"0001062993-22-018811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018811/form4.xml","form_type":"4"}},{"id":2172906,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T21:12:30.000Z","date":"2022-08-25","kind":"other","acquired":true,"shares":13076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":220666,"source":{"system":"sec-edgar","filing":"0001062993-22-018811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018811/form4.xml","form_type":"4"}},{"id":2172905,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T21:12:30.000Z","date":"2022-08-25","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":8419531,"source":{"system":"sec-edgar","filing":"0001062993-22-018811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018811/form4.xml","form_type":"4"}},{"id":2172904,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T21:12:30.000Z","date":"2022-08-25","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":6497132,"source":{"system":"sec-edgar","filing":"0001062993-22-018811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018811/form4.xml","form_type":"4"}},{"id":2172903,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T21:12:30.000Z","date":"2022-08-24","kind":"other","acquired":true,"shares":2952,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."}],"balance_after":46394,"source":{"system":"sec-edgar","filing":"0001062993-22-018811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018811/form4.xml","form_type":"4"}},{"id":2172902,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T21:12:30.000Z","date":"2022-08-24","kind":"other","acquired":true,"shares":1475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":23183,"source":{"system":"sec-edgar","filing":"0001062993-22-018811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018811/form4.xml","form_type":"4"}},{"id":2172901,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T21:12:30.000Z","date":"2022-08-24","kind":"other","acquired":true,"shares":13076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":207590,"source":{"system":"sec-edgar","filing":"0001062993-22-018811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018811/form4.xml","form_type":"4"}},{"id":2172900,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T21:12:30.000Z","date":"2022-08-24","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":8701750,"source":{"system":"sec-edgar","filing":"0001062993-22-018811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018811/form4.xml","form_type":"4"}},{"id":2172899,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T21:12:30.000Z","date":"2022-08-24","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":6714913,"source":{"system":"sec-edgar","filing":"0001062993-22-018811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018811/form4.xml","form_type":"4"}},{"id":2177037,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-22T21:14:32.000Z","date":"2022-08-18","kind":"other","acquired":true,"shares":2952,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."}],"balance_after":43442,"source":{"system":"sec-edgar","filing":"0001062993-22-018573","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018573/form4.xml","form_type":"4"}},{"id":2177036,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-22T21:14:32.000Z","date":"2022-08-18","kind":"other","acquired":true,"shares":1475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":21708,"source":{"system":"sec-edgar","filing":"0001062993-22-018573","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018573/form4.xml","form_type":"4"}},{"id":2177035,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-22T21:14:32.000Z","date":"2022-08-18","kind":"other","acquired":true,"shares":13076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":194514,"source":{"system":"sec-edgar","filing":"0001062993-22-018573","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018573/form4.xml","form_type":"4"}},{"id":2177034,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-22T21:14:32.000Z","date":"2022-08-18","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":8983969,"source":{"system":"sec-edgar","filing":"0001062993-22-018573","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018573/form4.xml","form_type":"4"}},{"id":2177033,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-22T21:14:32.000Z","date":"2022-08-18","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":6932694,"source":{"system":"sec-edgar","filing":"0001062993-22-018573","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018573/form4.xml","form_type":"4"}},{"id":2184280,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-16","kind":"other","acquired":true,"shares":2952,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."}],"balance_after":40490,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184279,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-16","kind":"other","acquired":true,"shares":1475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":20233,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184278,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-16","kind":"other","acquired":true,"shares":13076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":181438,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184277,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-16","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":9266188,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184276,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-16","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":7150475,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184275,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-15","kind":"other","acquired":true,"shares":2952,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."}],"balance_after":37538,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184274,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-15","kind":"other","acquired":true,"shares":1475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":18758,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184273,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-15","kind":"other","acquired":true,"shares":13076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":168362,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184272,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-15","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":9548407,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184271,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-15","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":7368256,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184270,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-12","kind":"other","acquired":true,"shares":2952,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."}],"balance_after":34586,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184269,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-12","kind":"other","acquired":true,"shares":1475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":17283,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184268,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-12","kind":"other","acquired":true,"shares":13076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":155286,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184267,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-12","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":9830626,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184266,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-12","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":7586037,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2236059,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-11T01:27:15.000Z","date":"2022-06-08","kind":"other","acquired":true,"shares":2952,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Reclassified shares previously reported as direct to indirect to reflect these shares are held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Reclassified shares previously reported as direct to indirect to reflect these shares are held by a trust for the benefit of family members of Bybee."}],"balance_after":31634,"source":{"system":"sec-edgar","filing":"0001062993-22-014696","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322014696/form4.xml","form_type":"4"}},{"id":2236058,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-11T01:27:15.000Z","date":"2022-06-08","kind":"other","acquired":true,"shares":1475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Reclassified shares previously reported as direct to indirect to reflect these shares are held by a trust for the benefit of family members of Bybee."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":15808,"source":{"system":"sec-edgar","filing":"0001062993-22-014696","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322014696/form4.xml","form_type":"4"}},{"id":2236057,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-11T01:27:15.000Z","date":"2022-06-08","kind":"other","acquired":true,"shares":13076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":142210,"source":{"system":"sec-edgar","filing":"0001062993-22-014696","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322014696/form4.xml","form_type":"4"}},{"id":2236056,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-11T01:27:15.000Z","date":"2022-06-08","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":10112845,"source":{"system":"sec-edgar","filing":"0001062993-22-014696","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322014696/form4.xml","form_type":"4"}},{"id":2236055,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-11T01:27:15.000Z","date":"2022-06-08","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":7803818,"source":{"system":"sec-edgar","filing":"0001062993-22-014696","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322014696/form4.xml","form_type":"4"}},{"id":2242432,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T00:24:33.000Z","date":"2022-06-02","kind":"other","acquired":true,"shares":4426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":43015,"source":{"system":"sec-edgar","filing":"0001062993-22-014426","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322014426/form4.xml","form_type":"4"}},{"id":2242431,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T00:24:33.000Z","date":"2022-06-02","kind":"other","acquired":true,"shares":13076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":129134,"source":{"system":"sec-edgar","filing":"0001062993-22-014426","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322014426/form4.xml","form_type":"4"}},{"id":2242430,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T00:24:33.000Z","date":"2022-06-02","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":10395064,"source":{"system":"sec-edgar","filing":"0001062993-22-014426","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322014426/form4.xml","form_type":"4"}},{"id":2242429,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T00:24:33.000Z","date":"2022-06-02","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":8021599,"source":{"system":"sec-edgar","filing":"0001062993-22-014426","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322014426/form4.xml","form_type":"4"}},{"id":2461100,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T22:59:59.000Z","date":"2021-12-20","kind":"other","acquired":true,"shares":15504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":38589,"source":{"system":"sec-edgar","filing":"0001062993-21-013385","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321013385/form4.xml","form_type":"4"}},{"id":2461099,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T22:59:59.000Z","date":"2021-12-20","kind":"other","acquired":true,"shares":45703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":116058,"source":{"system":"sec-edgar","filing":"0001062993-21-013385","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321013385/form4.xml","form_type":"4"}},{"id":2461098,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T22:59:59.000Z","date":"2021-12-20","kind":"other","acquired":false,"shares":987767,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":10677283,"source":{"system":"sec-edgar","filing":"0001062993-21-013385","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321013385/form4.xml","form_type":"4"}},{"id":2461097,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T22:59:59.000Z","date":"2021-12-20","kind":"other","acquired":false,"shares":762233,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":8239380,"source":{"system":"sec-edgar","filing":"0001062993-21-013385","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321013385/form4.xml","form_type":"4"}},{"id":2490760,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-01T23:30:38.000Z","date":"2021-11-29","kind":"other","acquired":true,"shares":4428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":23085,"source":{"system":"sec-edgar","filing":"0001062993-21-011917","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321011917/form4.xml","form_type":"4"}},{"id":2490759,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-01T23:30:38.000Z","date":"2021-11-29","kind":"other","acquired":true,"shares":13057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":70355,"source":{"system":"sec-edgar","filing":"0001062993-21-011917","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321011917/form4.xml","form_type":"4"}},{"id":2490758,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-01T23:30:38.000Z","date":"2021-11-29","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":11665050,"source":{"system":"sec-edgar","filing":"0001062993-21-011917","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321011917/form4.xml","form_type":"4"}},{"id":2490757,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-01T23:30:38.000Z","date":"2021-11-29","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":9001613,"source":{"system":"sec-edgar","filing":"0001062993-21-011917","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321011917/form4.xml","form_type":"4"}},{"id":2495378,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T22:58:15.000Z","date":"2021-11-22","kind":"other","acquired":true,"shares":4428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":18657,"source":{"system":"sec-edgar","filing":"0001062993-21-011643","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321011643/form4.xml","form_type":"4"}},{"id":2495377,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T22:58:15.000Z","date":"2021-11-22","kind":"other","acquired":true,"shares":13057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":57298,"source":{"system":"sec-edgar","filing":"0001062993-21-011643","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321011643/form4.xml","form_type":"4"}},{"id":2495376,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T22:58:15.000Z","date":"2021-11-22","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":11947269,"source":{"system":"sec-edgar","filing":"0001062993-21-011643","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321011643/form4.xml","form_type":"4"}},{"id":2495375,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T22:58:15.000Z","date":"2021-11-22","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":9219394,"source":{"system":"sec-edgar","filing":"0001062993-21-011643","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321011643/form4.xml","form_type":"4"}},{"id":2641331,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-06T20:47:23.000Z","date":"2021-07-01","kind":"other","acquired":true,"shares":8133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":14229,"source":{"system":"sec-edgar","filing":"0001062993-21-006362","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321006362/form4.xml","form_type":"4"}},{"id":2641330,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-06T20:47:23.000Z","date":"2021-07-01","kind":"other","acquired":true,"shares":25279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":44241,"source":{"system":"sec-edgar","filing":"0001062993-21-006362","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321006362/form4.xml","form_type":"4"}},{"id":2641329,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-06T20:47:23.000Z","date":"2021-07-01","kind":"other","acquired":false,"shares":2257752,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":12229488,"source":{"system":"sec-edgar","filing":"0001062993-21-006362","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321006362/form4.xml","form_type":"4"}},{"id":2641328,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-06T20:47:23.000Z","date":"2021-07-01","kind":"other","acquired":false,"shares":1742248,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":9437175,"source":{"system":"sec-edgar","filing":"0001062993-21-006362","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321006362/form4.xml","form_type":"4"}},{"id":2645036,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":8,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T21:19:09.000Z","date":"2021-06-30","kind":"other","acquired":true,"shares":4686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"Shares held directly by Nelsen."}],"balance_after":28111,"source":{"system":"sec-edgar","filing":"0001062993-21-006293","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000106299321006293/form4.xml","form_type":"4"}},{"id":2645035,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":8,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T21:19:09.000Z","date":"2021-06-30","kind":"other","acquired":true,"shares":811,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":4867,"source":{"system":"sec-edgar","filing":"0001062993-21-006293","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000106299321006293/form4.xml","form_type":"4"}},{"id":2645034,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":8,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T21:19:09.000Z","date":"2021-06-30","kind":"other","acquired":true,"shares":2555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":15328,"source":{"system":"sec-edgar","filing":"0001062993-21-006293","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000106299321006293/form4.xml","form_type":"4"}},{"id":2645033,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":8,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T21:19:09.000Z","date":"2021-06-30","kind":"other","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":2921519,"source":{"system":"sec-edgar","filing":"0001062993-21-006293","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000106299321006293/form4.xml","form_type":"4"}},{"id":2645032,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":8,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T21:19:09.000Z","date":"2021-06-30","kind":"other","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell, Robert Nelsen and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":2921520,"source":{"system":"sec-edgar","filing":"0001062993-21-006293","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000106299321006293/form4.xml","form_type":"4"}},{"id":2651887,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":8,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-29T21:22:25.000Z","date":"2021-06-29","kind":"other","acquired":true,"shares":4686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"Shares held directly by Nelsen."}],"balance_after":23425,"source":{"system":"sec-edgar","filing":"0001062993-21-006092","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000106299321006092/form4.xml","form_type":"4"}}],"next_cursor":"2021-06-29T21:22:25.000000Z,2651887"}